# Development of the Oncology Opportunity Cost Assessment Tool

> **NCT04694911** · — · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 40 (actual)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **BEHAVIORAL:** Focus Group
- **OTHER:** Interview
- **OTHER:** Research or Clinical Assessment Tool

## Key facts

- **NCT ID:** NCT04694911
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-21
- **Primary completion:** 2021-05-11
- **Final completion:** 2021-07-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04694911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04694911, "Development of the Oncology Opportunity Cost Assessment Tool". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04694911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*